ArticleCancers2026

Refusal of Guideline-Recommended Adjuvant Therapy in Oral Squamous Cell Carcinoma Is Associated with Less Favorable Survival Outcomes.

Lennart Johannes Gruber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.